Reported by Seeking Alpha · seekingalpha.com · August 12, 2026
Unicycive Therapeutics (UNCY) Q2 GAAP EPS beats estimates; cash $61.4M as of June 30, 2026 extends runway into 2027—read the update now.
What to watch: UNCY (UNCY) beat estimates by roughly $0.06 — check whether the reaction already prices in the surprise before chasing it.
Market reaction today: $UNCY -5.15%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.